반응식
[NH2:1][C@H](C(O)=O)CC1N=CNC=1.C([S:15][CH2:16][CH:17]([CH2:32][C:33]([O:35]C)=O)[C:18]([NH:20][C@H:21]([C:29]([OH:31])=[O:30])[CH2:22][CH2:23][CH2:24][NH:25][C:26](=N)[NH2:27])=[O:19])(=O)C>>[SH:15][CH2:16][CH:17]([CH2:32][C:33](=[O:35])[NH2:1])[C:18]([NH:20][C@H:21]([C:29]([OH:31])=[O:30])[CH2:22][C:23]1[N:27]=[CH:26][NH:25][CH:24]=1)=[O:19]참가 물질
3
실험 절차
By substituting Nα -[3-(acetylthio)-2-methoxycarbonylmethyl)propanoyl]-L-histidine for the Nα -[3-(acetylthio)-2-(methoxycarbonylmethyl)propanoyl]-L-arginine in the procedure of Example 19, Nα -[3-mercapto-2-(carbamoylmethyl)propanoyl]-L-histidine is obtained.
출처 및 근거
- ORD 기록
- ord-cf36d427c68348ddb6bb3383ca865368
- 출처 데이터셋
- uspto-grants-1979_05
- 특허 번호
- US04154736
연결된 노트
불러오는 중…